| Product Code: ETC8134333 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Parkinsons Disease Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Parkinsons Disease Market - Industry Life Cycle |
3.4 Malaysia Parkinsons Disease Market - Porter's Five Forces |
3.5 Malaysia Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Malaysia Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Malaysia Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Malaysia Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Malaysia Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Malaysia Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Malaysia |
4.2.2 Growing awareness and diagnosis rates of Parkinson's disease |
4.2.3 Advancements in healthcare infrastructure and technology in Malaysia |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease treatment and medication |
4.3.2 Limited access to specialized healthcare services for Parkinson's patients in certain regions of Malaysia |
5 Malaysia Parkinsons Disease Market Trends |
6 Malaysia Parkinsons Disease Market, By Types |
6.1 Malaysia Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Malaysia Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Malaysia Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Malaysia Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Malaysia Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Malaysia Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Malaysia Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Malaysia Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Malaysia Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Malaysia Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Malaysia Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Malaysia Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Malaysia Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Malaysia Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Malaysia Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Malaysia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Malaysia Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Malaysia Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Malaysia Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Malaysia Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Malaysia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Malaysia Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Malaysia Parkinsons Disease Market Export to Major Countries |
7.2 Malaysia Parkinsons Disease Market Imports from Major Countries |
8 Malaysia Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of Parkinson's disease diagnosis in Malaysia |
8.2 Number of neurologists specializing in movement disorders in Malaysia |
8.3 Percentage of Parkinson's disease patients receiving regular follow-up care |
9 Malaysia Parkinsons Disease Market - Opportunity Assessment |
9.1 Malaysia Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Malaysia Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Malaysia Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Malaysia Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Malaysia Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Malaysia Parkinsons Disease Market - Competitive Landscape |
10.1 Malaysia Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here